{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:28:35Z","timestamp":1791347315262,"version":"4.3.1"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,23]]},"DOI":"10.1097\/01.aids.0000183519.45137.a6","type":"journal-article","created":{"date-parts":[[2005,8,31]],"date-time":"2005-08-31T04:01:19Z","timestamp":1125460879000},"page":"1541-1543","source":"Crossref","is-referenced-by-count":49,"title":["Pharmacokinetic interactions between efavirenz and rifampicin in the treatment of HIV and tuberculosis: one size does not fit all"],"prefix":"10.1097","volume":"19","author":[{"given":"Paul","family":"Brennan-Benson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lyus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pakianathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Macallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"Dean","year":"2002","journal-title":"AIDS"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/thx.53.7.536","article-title":"Chemotherapy and management of tuberculosis in the United Kingdom: recommendations, 1998.","volume":"53","year":"1998","journal-title":"Thorax"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200241090-00004","article-title":"Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis","volume":"41","author":"Lopez-Cortes","year":"2002","journal-title":"Clin Pharmacokine"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002030-200101050-00011","article-title":"Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients","volume":"15","author":"Marzolini","year":"2001","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.aids.0000183519.45137.a6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:52:43Z","timestamp":1785855163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200509230-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,23]]},"references-count":5,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000183519.45137.a6","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9,23]]}}}